Executive Summary
The overnight filing set is dominated by M&A and insider activity, with the most critical development being NextEra Energy's voluntary supplemental disclosures for its $9B+ acquisition of Dominion Energy, which faces shareholder lawsuits threatening a September 3 vote.
A second major M&A signal comes from Navitas Semiconductor's agreement to acquire Claros for up to $232.8 million, doubling its addressable market to $8B+ and positioning it in AI data center power management — a high-growth thematic. Insider activity is mixed but notable: the CEO of Prenetics Global bought ~$239K in stock at ~$21.40, a strong bullish signal for a micro-cap, while Procore Technologies saw multiple C-suite tax-withholding sales totaling ~$4.9M at ~$63, which is typical but heavy in volume. On the negative side, the CEO of Fold Holdings sold stock at ~$0.48-0.49, and Namib Minerals’ beneficial owner disclosed a dilutive share loan of up to 14M shares carrying 13% interest, creating overhang. Teekay Tankers awarded dividend equivalent rights, signaling a steady return of capital. XPeng and Vipshop both filed unremarkable 6-Ks. Period-over-period trends are sparse, but Molecular Partners showed a 28% YoY improvement in net loss to CHF -26.7M, a positive turn in cash burn. The overall tone is neutral-to-bullish on M&A and selected insider buys, with material risk from litigation and dilution in a few names.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Schedule 13D · Form 4 · 425 · 8-K
Tracking the trend? Catch up on the prior US Pre-Market SEC Filings Roundup digest from August 17, 2026.
Investment Signals (10)
- Navitas Semiconductor ↓ (BULLISH)▲
Definitively acquired Claros for ~$232.8M, doubling TAM to over $8B by 2030, unanimously approved by both boards, closing expected before year-end 2026 — positions firmly in AI data center power chain
- Prenetics Global Ltd ↓ (BULLISH)▲
CEO Yeung Danny Sheng Wu bought 11,181 shares at ~$21.40 (~$239K total), following an earlier exercise of 53,953 RSUs at $0 — a significant insider vote of confidence in a micro-cap, with total holdings now 112,416 shares
- ▲
Merger facing two shareholder lawsuits (Scott v. Dominion, Clark v. Dominion) alleging negligent misrepresentation; NextEra voluntarily supplementing disclosures to moot claims and avoid delay — vote scheduled for Sept 3, 2026, any delay risks spread widening
-
Multiple C-suite members (CEO, CLO, President Product & Technology, SVP Controller) had shares withheld for taxes at ~$62.92, totaling ~$4.9M in notional value — while tax-related, the volume is high and suggests insider willingness to realize value at current levels [NEUTRAL/BEARISH]
- Fold Holdings ↓ (BEARISH)▲
CEO Reeves sold 10,045 shares at ~$0.49 and 8,911 shares at ~$0.48 (~$9.1K total) — consistent selling by the top executive is a red flag for a low-priced crypto-adjacent stock
- CTT Pharmaceutical Holdings ↓ (BULLISH)▲
CEO bought 2,100 shares at $0.06 (~$116 total), increasing holdings to 9.36M shares — a token buy but a positive signal for a micro-cap trading at $0.06
- Venu Holding Corp ↓ (BULLISH)▲
CEO & Chairman ROTH JAY W bought 1,000 shares at $1.92 (~$1.9K), increasing holdings to 9.27M shares — small purchase but follows insider buying pattern
- Equinor ASA ↓ (BULLISH)▲
Under third tranche of 2026 buyback program, repurchased 721,000 shares at avg NOK 394.76 (~$34M) in the week of Aug 17-21; accumulated 2.93M shares at avg NOK 384.93 — steady repurchase execution supports share price
- Molecular Partners AG ↓ (BULLISH)▲
H1 2026 net loss improved to CHF -26.7M from CHF -37.2M in H1 2025 (28% YoY improvement), zero restructuring expenses, improved net finance result — cash burn is moderating despite fell 18% to CHF 67.9M
- Namib Minerals ↓ (BEARISH)▲
Beneficial owner Mzilikazi Godfrey Khumalo sold ~4.89M shares at ~$3.46 and entered a share loan agreement for up to 14M shares with 13% annual interest and a $50K upfront fee — creates significant potential dilution and off-balance-sheet exposure, while lender holds security interest in 3M earnout shares
Risk Flags (8)
- NextEra Energy/Dominion Merger Litigation↓ [HIGH RISK]▼
Two shareholder lawsuits filed in New York Supreme Court alleging negligent misrepresentation, concealment, and negligence; combined with voluntary supplemental disclosures, risk of delayed closing or injunction — shareholder vote Sept 3, 2026
- Namib Minerals Dilution Risk↓ [HIGH RISK]▼
Beneficial owner's loan of up to 14M shares at 13% interest p.a. plus $50K fee creates a massive overhang equivalent to ~3.5x his disclosed beneficial ownership (4M shares); if borrower defaults, lender gets 3M earnout shares — severe dilution headwind
- Procore Technologies Insider Selling Pattern [MEDIUM RISK]▼
While tax-withholding sales are standard, the scale ($4.9M across 5 top officers in a single filing cycle at ~$62.92) suggests a coordinated realization event — watch for additional 10b5-1 sales by the CEO and CLO who already have active plans
- Quantum Computing Inc CEO Award↓ [MEDIUM RISK]▼
CEO Huang Yuping was awarded 584,897 shares at $0.00 (~$58.5 notional) via warrant exercise, increasing holdings to 21.5M shares — massive dilution already reflected in filing, but warrants represent ongoing overhang
- Fold Holdings CEO Selling [MEDIUM RISK]▼
Two sales in quick succession (8,911 shares at $0.48, 10,045 shares at $0.49) by the CEO — first insider sales since prior period; for a micro-cap crypto company, this signals waning confidence
- Regenerative Medical Technology Group Debt Load [MEDIUM RISK]▼
CEO noted 'significant liabilities and growing interest expense' from financing expansion (Global Stem Cell Group acquisition); Q1 revenue up 90% YoY and Q2 quadrupled, but debt service could pressure cash flows; Nasdaq uplisting timeline uncertain
- Molecular Partners AG Cash Runway↓ [MEDIUM RISK]▼
Cash fell 18% to CHF 67.9M from CHF 82.7M at year-end 2025, with zero revenue from collaborations — despite improved net loss, burn rate implies ~2.5 years of runway at current pace, requiring future capital raise
- Roivant Sciences Form 4 Parsing Failure [LOW RISK]▼
Two filings (#2 and #5) had structured EDGAR documents that could not be retrieved for automated parsing — this may indicate data integrity issues for key transactions in a high-profile biotech
Opportunities (8)
- Navitas Semiconductor / Claros Merger↓ (OPPORTUNITY)◆
Acquiring Claros for ~$232.8M in a cash/stock deal to gain VPD and IVR technology for AI data centers; doubles TAM to $8B+ and extends grid-to-xPU portfolio; closi ng expected by year-end 2026 — buy on merger-related dip, as profitability timeline unchanged
- Prenetics Global CEO Buy (OPPORTUNITY)◆
CEO Yeung purchased 11,181 shares at $21.40 (~$239K), his second open-market buy in the period after earlier $137K purchase at $18.31; total insider holdings now 112,416 shares — significant conviction for a micro-cap trading at $21.40, with RSU exercises also occurring
- Equinor ASA Buyback Execution↓ (OPPORTUNITY)◆
Week 3 of third tranche saw 721,000 shares repurchased at avg NOK 394.76, with rising average price from NOK 387.77 to NOK 399.47 — steady buyback support provides floor; international oil & gas exposure with strong cash returns
- Molecular Partners Cost Improvement (OPPORTUNITY)◆
H1 2026 net loss improved 28% YoY to CHF -26.7M; restructuring expenses eliminated, net finance result positive at CHF +0.3M vs -CHF 3.7M in H1 2025 — cash burn trending in right direction; catalyst if pipeline advances on zero-revenue platform
- Venu Holding Corp Insider Buy↓ (OPPORTUNITY)◆
CEO Jay Roth bought 1,000 shares at $1.92, increasing already large position to 9.27M shares — at ~$1.92, the stock trades below insider's average purchase price; small transaction but consistent with insider bullishness
- CTT Pharmaceutical CEO Buy (SPECULATIVE OPPORTUNITY)◆
Token purchase of 2,100 shares at $0.06 (~$116) but CEO now holds 9.36M shares — for a stock trading at pennies, insider buying aligns with penny stock speculation; upside if any pipeline news emerges
- Regenerative Medical Technology Growth Trajectory (SPECULATIVE OPPORTUNITY)◆
Q1 2026 revenue grew 90% YoY and Q2 revenue quadrupled — despite debt, top-line growth is accelerating; new lab and biologics license in Argentina are catalysts; Nasdaq uplisting could unlock institutional investment
- Teekay Tankers Dividend Equivalent Rights (OPPORTUNITY)◆
Chief Commercial Officer awarded 99.6 Dividend Equivalent Rights — implies company continues to pay dividends and award them to insiders; tanker rates may be improving; watch Q3 earnings for cash flow rebound
Sector Themes (6)
- M&A Disclosure Litigation Surge◆
Two companies (NextEra Energy/Dominion and NEXTERA ENERGY) filed supplemental disclosures in response to shareholder demand letters and lawsuits alleging disclosure deficiencies — this trend of pre-vote litigation is becoming standard in large M&A, creating short-term volatility risk around vote dates (Sept 3 for Dominion)
- Insider Activity Divergence: CEO Buys vs CFO Sells◆
In this batch, CEOs of Prenetics and Venu Holding made open-market purchases, while CFO at Fold Holdings sold — executives at the top are showing confidence, while financial chiefs and legal officers (Procore CLO) are selling; pattern suggests insiders see value at smaller caps but not at mid-cap software names trading near $63
- AI Data Center Infrastructure Spend Driving M&A◆
Navitas Semiconductor's acquisition of Claros is the second AI-infrastructure deal in this filing set; the $232.8M deal extends grid-to-xPU power management for data centers, doubling TAM to $8B+ — expect more bolt-on acquisitions as chip companies race to integrate power solutions for AI workloads
-
Molecular Partners (zero revenue) reported a 28% YoY improvement in net loss to CHF -26.7M, with no restructuring costs and improved finance results — a modest but positive trend for cash-strapped biotechs; watch for similar patterns in other European biotech filings
- Steady Buyback Execution in Energy◆
Equinor's weekly buyback disclosure shows consistent repurchase activity (721K shares/week, ~$34M), with rising average price — this contrasts with the M&A activity in NextEra/Dominion, suggesting European energy majors remain committed to returning capital even as US utilities pursue consolidation
- Small-Cap Insider Buying Clusters◆
Three micro-cap companies (Prenetics at $21.40, Venu at $1.92, CTT at $0.06) saw CEO purchases this filing period — a cluster of insider buying at the lowest end of market cap spectrum often precedes turnaround attempts or pre-announcements; note all three are sub-$300M market cap
Watch List (8)
-
Shareholder vote scheduled for September 3, 2026; two lawsuits pending (Scott v. Dominion, Clark v. Dominion); voluntary supplements could mooter claims; watch for proxy advisors' recommendations (ISS, Glass Lewis) in next 7 days — will set tone for deal completion probability
-
Expected before year-end 2026, subject to regulatory approvals; watch for any anti-trust scrutiny given Navitas' market position in GaN power; also monitor competitor responses (Infineon, onsemi) that could impact deal economics
- Procore Technologies Insider Sales👁
With $4.9M in tax-withholding sales at ~$62.92 and an active 10b5-1 plan for the CLO, watch for additional SEC Form 144 filings signaling open-market sales; stock price action around $63 is key resistance level
- Fold Holdings CEO Sales👁
CEO Reeves sold 18,956 shares in two trades at $0.48-0.49; check next week's Form 4 for additional sales; if CEO continues selling into any rally, it's a bearish signal for the crypto-adjacent stock
- Regenerative Medical Technology Group Nasdaq Uplisting👁
CEO stated timing cannot be guaranteed but Nasdaq uplisting checklist is being followed; watch for any Form S-1 or 8-K filing regarding reverse stock split or shareholder approval — could be a catalyst if uplisting achieved
-
Weekly disclosures will continue under 2026 program; watch for any reduction in repurchase pace (current ~721K/week) which could signal capex shift or cash allocation change
-
Filed 6-K with Q2 2026 unaudited results; the exhibits contain full financials (not parsed here) — watch for delivery numbers, margins, and guidance; Chinese EV sector is highly competitive and XPENG's cash position is critical
- Bit Digital Ownership Structure👁
SC 13D/A shows CFO holds 15.2% voting power via preference shares with 50x voting rights — creates dual-class risk; watch for any shareholder activism or governance challenges given the concentrated control
Filing Analyses
(50)
24-08-2026
Mzilikazi Godfrey Khumalo filed a Schedule 13D/A disclosing two significant transactions in Namib Minerals ordinary shares: (i) the sale of 4,886,996 shares at an average of ~$3.46/share between August 2025 and February 2026, and (ii) a share loan agreement dated June 29, 2026, with Southern SelliBen Trust under which Khumalo borrowed up to 14 million shares. Following the sale, Khumalo’s beneficial ownership dropped from 7.1% to 7.1% (stated as 4,000,000 shares still held), but the share loan adds substantial off-balance-sheet exposure and potential dilution risk, while the lender holds a security interest in Khumalo’s future earnout shares (3 million shares) to secure repayment.
- · The share loan agreement was executed on June 29, 2026, with Southern SelliBen Trust as lender and Mzilikazi Godfrey Khumalo as borrower.
- · Khumalo borrowed up to 14 million ordinary shares and must redeliver up to 14 million Equivalent Shares (or pay cash value) by the Longstop Date or upon written notice from the lender.
- · The loan carries a $50,000 upfront fee plus 13% p.a. interest, payable monthly, calculated on the value of the loaned shares at closing price on the loan date.
- · Khumalo granted the lender a security interest in his earnout shares (up to 3 million shares) as collateral for the loan.
- · Khumalo's beneficial ownership remained at 7.1% of the outstanding shares, but the loan adds significant off-balance-sheet share exposure (up to 14M shares) and potential dilution if the earnout shares are not received.
- · The reporting person is a South African citizen, resident in Geneva, Switzerland, and his principal occupation is investor/entrepreneur.
- · No other person has the right to receive dividends or proceeds from the sale of the shares held by Khumalo.
24-08-2026
Form 4 ownership filing; the structured EDGAR document could not be retrieved for automated parsing.
24-08-2026
Chief Executive Officer Simpson Stuart was awarded 44,013 Nil Cost Options.
- · Chief Executive Officer Simpson Stuart was awarded 44,013 Nil Cost Options
24-08-2026
President & Immunovant CEO Venker Eric had withheld for taxes 13,909 Common Shares at $36.84 (~$512K). Venker Eric holds 1,599,154 shares after the transaction.
- · President & Immunovant CEO Venker Eric had withheld for taxes 13,909 Common Shares at $36.84 (~$512K)
24-08-2026
Form 4 ownership filing; the structured EDGAR document could not be retrieved for automated parsing.
24-08-2026
Director Courtemanche Craig F. Jr. had withheld for taxes 11,388 Common Stock at $62.92 (~$717K). Courtemanche Craig F. Jr. holds 908,316 shares after the transaction.
- · Director Courtemanche Craig F. Jr. had withheld for taxes 11,388 Common Stock at $62.92 (~$717K)
24-08-2026
Chief Legal Officer; Secretary Singer Benjamin C had withheld for taxes 5,849 Common Stock at $62.92 (~$368K). Singer Benjamin C holds 86,931 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Legal Officer; Secretary Singer Benjamin C had withheld for taxes 5,849 Common Stock at $62.92 (~$368K)
- · Chief Legal Officer; Secretary Singer Benjamin C sold 3,943 Common Stock at $63.35 (~$250K)
24-08-2026
Director Huang Ya-Chi exercised/converted 500 CLASS A ORDINARY SHARES. Huang Ya-Chi holds 1,500 shares after the transaction.
- · Director Huang Ya-Chi exercised/converted 500 CLASS A ORDINARY SHARES
- · Director Huang Ya-Chi exercised/converted 500 Restricted Stock Units
24-08-2026
CEO CTT PHARMACEUTICAL HOLDINGS, INC. bought 2,100 CTTH at $0.06 (~$116). CTT PHARMACEUTICAL HOLDINGS, INC. holds 9,360,756 shares after the transaction.
- · CEO CTT PHARMACEUTICAL HOLDINGS, INC. bought 2,100 CTTH at $0.06 (~$116)
24-08-2026
CEO and President Huang Yuping was awarded 584,897 Common Stock at $0.00 (~$58.5). This amends a previously filed Form 4. Huang Yuping holds 21,531,173 shares after the transaction.
- · CEO and President Huang Yuping was awarded 584,897 Common Stock at $0.00 (~$58.5)
- · CEO and President Huang Yuping exercised/converted 584,897 Warrants to Purchase Shares of Common Stock
24-08-2026
CEO & Chairman ROTH JAY W bought 1,000 Common Stock, par value $0.001 at $1.92 (~$1.92K). ROTH JAY W holds 9,270,864 shares after the transaction.
- · CEO & Chairman ROTH JAY W bought 1,000 Common Stock, par value $0.001 at $1.92 (~$1.92K)
24-08-2026
CEO & President Gopal Ajei had withheld for taxes 45,088 Common Stock at $62.92 (~$2.84M). Gopal Ajei holds 508,346 shares after the transaction.
- · CEO & President Gopal Ajei had withheld for taxes 45,088 Common Stock at $62.92 (~$2.84M)
24-08-2026
President Product & Technology Davis Steven Scott had withheld for taxes 13,267 Common Stock at $62.92 (~$835K). Davis Steven Scott holds 277,282 shares after the transaction.
- · President Product & Technology Davis Steven Scott had withheld for taxes 13,267 Common Stock at $62.92 (~$835K)
24-08-2026
SVP, Corporate Controller Fleming William Fred Jr had withheld for taxes 2,308 Common Stock at $62.92 (~$145K). Fleming William Fred Jr holds 102,673 shares after the transaction.
- · SVP, Corporate Controller Fleming William Fred Jr had withheld for taxes 2,308 Common Stock at $62.92 (~$145K)
24-08-2026
EVP, CRO, Enterprise Norton James Michael exercised/converted 10,593 Common Stock. 4 transactions reported in total. Norton James Michael holds 13,464 shares after the transaction.
- · EVP, CRO, Enterprise Norton James Michael exercised/converted 10,593 Common Stock
- · EVP, CRO, Enterprise Norton James Michael was awarded 426 Common Stock
- · EVP, CRO, Enterprise Norton James Michael had withheld for taxes 1,685 Common Stock
- · EVP, CRO, Enterprise Norton James Michael exercised/converted 10,593 Restricted Share Units
24-08-2026
Chief Executive Officer Reeves William Brian Poppic sold 10,045 Common Stock at $0.49 (~$4.9K). Reeves William Brian Poppic holds 5,450,417 shares after the transaction.
- · Chief Executive Officer Reeves William Brian Poppic sold 8,911 Common Stock at $0.48 (~$4.24K)
- · Chief Executive Officer Reeves William Brian Poppic sold 10,045 Common Stock at $0.49 (~$4.9K)
24-08-2026
Form 4 ownership filing; the structured EDGAR document could not be retrieved for automated parsing.
24-08-2026
Director Tilzer Brian A was awarded 8.67 Common Shares, par value $0.18. Tilzer Brian A holds 14,626.68 shares after the transaction.
- · Director Tilzer Brian A was awarded 8.67 Common Shares, par value $0.18
24-08-2026
Director COCHRAN SANDRA B was awarded 8.67 Common Shares, par value $0.18. COCHRAN SANDRA B holds 6,177.68 shares after the transaction.
- · Director COCHRAN SANDRA B was awarded 8.67 Common Shares, par value $0.18
24-08-2026
Director Gennette Jeffrey was awarded 9.84 Common Shares, par value $0.18. Gennette Jeffrey holds 2,340.84 shares after the transaction.
- · Director Gennette Jeffrey was awarded 9.84 Common Shares, par value $0.18
24-08-2026
Director Hicks Zackery A was awarded 8.67 Common Shares, par value $0.18. Hicks Zackery A holds 20,472.68 shares after the transaction.
- · Director Hicks Zackery A was awarded 8.67 Common Shares, par value $0.18
24-08-2026
Director MCCOLLAM SHARON was awarded 8.67 Common Shares, par value $0.18. MCCOLLAM SHARON holds 32,745.68 shares after the transaction.
- · Director MCCOLLAM SHARON was awarded 8.67 Common Shares, par value $0.18
24-08-2026
Director Graf R. Mark was awarded 8.67 Common Shares, par value $0.18. Graf R. Mark holds 33,649.68 shares after the transaction.
- · Director Graf R. Mark was awarded 8.67 Common Shares, par value $0.18
24-08-2026
Director McCluskey Helen was awarded 15.6 Common Shares, par value $0.18. McCluskey Helen holds 39,396.87 shares after the transaction.
- · Director McCluskey Helen was awarded 15.6 Common Shares, par value $0.18
24-08-2026
Director Wilson Donta L was awarded 8.67 Common Shares, par value $0.18. Wilson Donta L holds 13,585.68 shares after the transaction.
- · Director Wilson Donta L was awarded 8.67 Common Shares, par value $0.18
24-08-2026
Director Ulasewicz Eugenia was awarded 8.67 Common Shares, par value $0.18. Ulasewicz Eugenia holds 26,822.68 shares after the transaction.
- · Director Ulasewicz Eugenia was awarded 8.67 Common Shares, par value $0.18
24-08-2026
Chief Accounting Officer Ciccolini Vincent was awarded 21.11 Common Shares, par value $0.18. Ciccolini Vincent holds 45,256.78 shares after the transaction.
- · Chief Accounting Officer Ciccolini Vincent was awarded 21.11 Common Shares, par value $0.18
24-08-2026
See Remarks Sagi Raghunandan R was awarded 47.41 Common Shares, par value $0.18. Sagi Raghunandan R holds 11,081.89 shares after the transaction.
- · See Remarks Sagi Raghunandan R was awarded 47.41 Common Shares, par value $0.18
24-08-2026
Chief Financial Officer Lo Hoi Chun exercised/converted 491,029 Restricted Stock Unit at $0.00 (~$49.1). 4 transactions reported in total. Lo Hoi Chun holds 566,013 shares after the transaction.
- · Chief Financial Officer Lo Hoi Chun exercised/converted 32,736 Class A Ordinary Share, par value $0.0015 per share at $0.00 (~$3.27)
- · Chief Financial Officer Lo Hoi Chun exercised/converted 45,815 Class A Ordinary Share, par value $0.0015 per share
- · Chief Financial Officer Lo Hoi Chun exercised/converted 45,815 Restricted Stock Unit
- · Chief Financial Officer Lo Hoi Chun exercised/converted 491,029 Restricted Stock Unit at $0.00 (~$49.1)
24-08-2026
Chief People Officer Cho Karen Leslie was awarded 31.27 Common Shares, par value $0.18. Cho Karen Leslie holds 8,486.77 shares after the transaction.
- · Chief People Officer Cho Karen Leslie was awarded 31.27 Common Shares, par value $0.18
24-08-2026
* See Remarks Hilson Joan M was awarded 318.45 Common Shares, par value $0.18. Hilson Joan M holds 258,949.61 shares after the transaction.
- · * See Remarks Hilson Joan M was awarded 318.45 Common Shares, par value $0.18
24-08-2026
See Remarks Yoakum Julie was awarded 52.39 Common Shares, par value $0.18. Yoakum Julie holds 12,245.32 shares after the transaction.
- · See Remarks Yoakum Julie was awarded 52.39 Common Shares, par value $0.18
24-08-2026
See Remarks Cividino Claudia was awarded 34.96 Common Shares, par value $0.18. Cividino Claudia holds 17,114.1 shares after the transaction.
- · See Remarks Cividino Claudia was awarded 34.96 Common Shares, par value $0.18
24-08-2026
* See Remarks Ptak Stash was awarded 25.16 Common Shares, par value $0.18. Ptak Stash holds 23,968.21 shares after the transaction.
- · * See Remarks Ptak Stash was awarded 25.16 Common Shares, par value $0.18
24-08-2026
Chief Executive Officer Symancyk James Kevin was awarded 384.04 Common Shares, par value $0.18. Symancyk James Kevin holds 149,542.81 shares after the transaction.
- · Chief Executive Officer Symancyk James Kevin was awarded 384.04 Common Shares, par value $0.18
24-08-2026
Chief Executive Officer Yeung Danny Sheng Wu bought 11,181 Class A Ordinary Share, par value $0.0015 per share at $21.40 (~$239K). 6 transactions reported in total. Yeung Danny Sheng Wu holds 112,416 shares after the transaction.
- · Chief Executive Officer Yeung Danny Sheng Wu exercised/converted 53,953 Class A Ordinary Share, par value $0.0015 per share at $0.00 (~$5.4)
- · Chief Executive Officer Yeung Danny Sheng Wu disposed of 49,912 Class A Ordinary Share, par value $0.0015 per share
- · Chief Executive Officer Yeung Danny Sheng Wu bought 7,500 Class A Ordinary Share, par value $0.0015 per share at $18.31 (~$137K)
- · Chief Executive Officer Yeung Danny Sheng Wu bought 6,000 Class A Ordinary Share, par value $0.0015 per share at $20.90 (~$125K)
- · Chief Executive Officer Yeung Danny Sheng Wu bought 11,181 Class A Ordinary Share, par value $0.0015 per share at $21.40 (~$239K)
- · Chief Executive Officer Yeung Danny Sheng Wu exercised/converted 809,295 Restricted Stock Unit at $0.00 (~$80.9)
24-08-2026
Erke Huang, CFO and director of Bit Digital, Inc., filed an amended Schedule 13D disclosing beneficial ownership of securities representing approximately 15.2% of the company's voting power as of August 21, 2026. The filing details ownership changes including the exchange of 1,000,000 ordinary shares for preference shares held by Geney Development Ltd., which are entitled to 50 votes per share, allowing management to maintain voting control. Notably, while Mr. Huang reports sole and shared voting power over a significant number of securities, the overall voting percentage reflects the impact of these high-vote preference shares in a company with over 360 million ordinary shares outstanding.
- · Mr. Huang is President of Geney Development Limited and holds 30% beneficial interest in Geney's shares; Zhaohui Deng holds the remaining 70%.
- · 200,000 preference shares held by Even Green Holdings Ltd. were issued in consideration of the growth of the Issuer and for Mr. Huang's performance.
- · The preference shares were issued upon shareholder approval in exchange for ordinary shares; each preference share carries 50 votes.
- · No criminal or civil proceedings involving Mr. Huang are disclosed.
24-08-2026
Form 4 ownership filing; the structured EDGAR document could not be retrieved for automated parsing.
24-08-2026
Chief Commercial Officer Seidelin Mikkel was awarded 99.6417 Dividend Equivalent Rights.
- · Chief Commercial Officer Seidelin Mikkel was awarded 99.6417 Dividend Equivalent Rights
25-08-2026
NextEra Energy (NEE) is voluntarily supplementing its joint proxy statement/prospectus for its planned acquisition of Dominion Energy to address shareholder demand letters alleging disclosure deficiencies. The supplemental disclosures provide additional details on the merger background, including discussions with Party A, and Lazard's financial analyses. NextEra Energy maintains that the original disclosures comply with applicable law and that the allegations are without merit; the voluntary supplementation is intended to moot the claims and avoid any delay in closing.
- · On March 26, 2026, Mr. Blue called Party A's CEO, informing him Dominion Energy's board required a higher premium from Party A but was prepared to proceed with diligence subject to a non-disclosure and standstill agreement.
- · On March 27, 2026, a Non-Disclosure and Standstill Agreement with Party A was executed, including a standstill restriction that expired upon Dominion Energy's entry into a definitive agreement.
- · The supplemental disclosures detail Lazard's sum-of-the-parts DCF and company comparables analyses for both NextEra Energy and Dominion Energy, including the calculation of net debt (including finance leases, preferred equity, noncontrolling interest, less cash/equivalents and equity method investments).
- · Lazard used a discount rate range for each segment based on estimated WACC and selected exit multiples based on professional judgment.
- · Comparable analysis for NextEra Energy's Premium Utility Peers (2026E/2027E Price/Adjusted EPS) showed means of 20.5x/18.8x and top quartiles of 21.0x/19.4x; Premium Independent Power Producer Peers (2026E/2027E EV/Adjusted EBITDA) showed means of 12.6x/11.5x and top quartiles of 13.5x/12.4x.
- · Comparable analysis for Dominion Energy's Utility Peers (2026E/2027E Price/Adjusted EPS) showed means of 18.5x/17.2x and top quartiles of 19.2x/17.7x; Premium Independent Power Producer Peers (2026E/2027E EV/Adjusted EBITDA) had the same mean and top quartile as NextEra Energy's IPP peer group.
25-08-2026
Vipshop Holdings Ltd filed a Form 6-K with the SEC on August 25, 2026, attaching a press release reporting its unaudited second quarter 2026 financial results. The filing includes the company's address in Guangzhou, China, and is signed by CFO Mark Wang. No specific financial figures are disclosed in the filing itself, only the announcement of results.
- · Filing is a Form 6-K for the month of August 2026
- · Commission File Number: 001-35454
- · Address: Vipshop Headquarters, 128 Dingxin Road, Haizhu District, Guangzhou 510220, People's Republic of China
- · The press release (Exhibit 99.1) covers unaudited second quarter 2026 financial results
25-08-2026
On August 20, 2026, Regenerative Medical Technology Group Inc. held an investor video call where management provided business updates. CEO Dave Christensen noted that Q1 2026 revenue grew 90% year-over-year and Q2 revenue quadrupled versus the prior year, driven by ISSCA education and Cellgenic product sales. However, the company carries significant debt and growing interest expense from financing its expansion, and CEO cautioned that the timing for a Nasdaq uplisting cannot be guaranteed. The call also highlighted recent milestones including a new laboratory and a first-of-its-kind biologics license in Argentina, but no new financial figures or specific guidance were disclosed.
- · The company held an investor video call on August 20, 2026; a transcript was furnished as Exhibit 99.1.
- · CEO mentioned helping a company lead an IPO in 2018 and described the Nasdaq uplisting checklist requirements.
- · The company carries significant liabilities and growing interest expense from financing the acquisition of Global Stem Cell Group and other expansion.
- · The BKFC partnership makes RMTG the league's official regenerative medicine partner for treating fighters.
- · Over 478 doctors attended the previous September annual event.
- · The company is opening a new laboratory and obtained a first-of-its-kind biologics license in Argentina.
- · Affiliate model provides recurring revenue through a membership-like tier system for doctors.
- · The Cancun facility is located in a medical destination central area with world-class facilities.
25-08-2026
Equinor ASA disclosed transactions under the third tranche of its 2026 share buy-back programme, covering the week of August 17-21, 2026. During this period, the company repurchased 721,000 shares on the Oslo Stock Exchange (OSE) at a weighted average price of NOK 394.7557, for a total transaction value of NOK 284,618,893.20. Accumulated buy-backs under the tranche now total 2,928,004 shares at a weighted average price of NOK 384.9271, with a total value of NOK 1,127,068,112.50. The daily volume declined from 148,000 to 140,000 shares over the week, while the weighted average price rose from NOK 387.7655 to NOK 399.4722.
- · All transactions were executed on the Oslo Stock Exchange (OSE); no activity on CEUX or TQEX.
- · Daily weighted average share price ranged from NOK 387.7655 to NOK 399.4722 during the week.
- · Previously disclosed buy-backs under the tranche: 2,207,004 shares at a weighted average price of NOK 381.7162.
25-08-2026
ING Groep N.V. filed a Form 6-K with the SEC on August 25, 2026, attaching a press release issued the same day. The filing is a routine foreign issuer report under Rule 13a-16, with no financial results or material business updates disclosed in the 6-K itself.
- · The press release is attached as Exhibit 99.1 but its content is not summarized in the 6-K.
- · The filing is for the month of August 2026 under Commission File Number 001-14642.
25-08-2026
HDFC Bank Ltd filed a Form 6-K with the SEC for the month of August 2026, as a routine foreign private issuer report. The filing includes a disclosure exhibit (Exhibit 99) but no specific financial results, material events, or period-over-period comparisons are provided in the filing content. The report is a procedural compliance filing with no substantive business updates.
- · Filing is a Form 6-K for the month of August 2026 under the Securities Exchange Act of 1934.
- · Commission File Number: 001-15216.
- · Registrant's address: HDFC Bank House, Senapati Bapat Marg, Lower Parel, Mumbai 400 013, India.
- · The registrant indicates it files annual reports under Form 20-F.
- · Exhibit 99 is referenced as 'Disclosure' but no content is provided in the filing text.
25-08-2026
Molecular Partners AG reported an improved net result for H1 2026, with a net loss of CHF 26.7M compared to a net loss of CHF 37.2M in H1 2025, a 28% reduction in year-over-year losses. The company continues to have zero revenue from collaborations and reduced its cash burn, though cash and cash equivalents fell 18% to CHF 67.9M from CHF 82.7M at year-end 2025.
- · The company had zero revenue from research and development collaborations in both H1 2026 and H1 2025.
- · Restructuring expenses were nil in H1 2026 compared to CHF 2.6M in H1 2025.
- · Net finance result swung to positive CHF 0.3M in H1 2026 from a loss of CHF 3.7M in H1 2025, primarily due to the absence of net foreign exchange losses.
- · Basic and diluted net result per share improved to CHF (0.70) in H1 2026 from CHF (1.00) in H1 2025.
- · Cash used in operations decreased to CHF 25.0M from CHF 30.2M, a 17% improvement.
- · Shareholders' equity declined 27% to CHF 58.5M from CHF 80.3M due to the net loss and other comprehensive income items.
25-08-2026
XPENG INC. filed a Form 6-K with the SEC on August 25, 2026, reporting its unaudited financial results for the second quarter of 2026 and interim results for the six months ended June 30, 2026. The filing includes a press release (Exhibit 99.1) and an interim results announcement (Exhibit 99.2). No specific financial figures are provided in the filing itself, only references to the exhibits.
- · Filing type: Form 6-K (Report of Foreign Private Issuer)
- · Filing date: August 25, 2026
- · Commission File Number: 001-39466
- · Exhibit 99.1: Press Release - XPENG Reports Second Quarter 2026 Unaudited Financial Results
- · Exhibit 99.2: Announcement - Interim Results Announcement for the Six Months Ended June 30, 2026
- · Signed by Xiaopeng He, Chairman and CEO
25-08-2026
NextEra Energy is voluntarily supplementing its joint proxy statement/prospectus related to its pending acquisition of Dominion Energy, following demand letters from shareholders alleging disclosure deficiencies. The company denies the allegations and believes its disclosures comply with applicable law, but is providing supplemental information to moot the claims and avoid delays. The supplemental disclosures include additional details on the merger background and financial analyses by Lazard.
- · The Merger Agreement was entered into on May 15, 2026.
- · The Registration Statement on Form S-4 was declared effective by the SEC on July 23, 2026.
- · The definitive joint proxy statement/prospectus was filed on July 28, 2026.
- · NextEra Energy received demand letters from purported shareholders alleging disclosure deficiencies in the joint proxy statement/prospectus.
- · Supplemental disclosures include details on a March 26, 2026 call between Mr. Blue and Party A's CEO regarding Dominion Energy's required premium.
- · Lazard's financial analyses include sum-of-the-parts DCF and company comparables for both NextEra Energy and Dominion Energy, with specific valuation multiples for peer companies.
25-08-2026
Dominion Energy is supplementing its definitive proxy statement related to its pending acquisition by NextEra Energy, following shareholder demand letters and two lawsuits alleging disclosure deficiencies. The company denies the allegations and believes no supplemental disclosures are required, but is voluntarily providing additional details to avoid delays and minimize expense. The supplemental disclosures include new background details on negotiations with a third party (Party A) and expanded financial analyses from NextEra Energy's financial advisor, Lazard.
- · Shareholder meeting to vote on the merger is scheduled for September 3, 2026.
- · Two shareholder lawsuits filed in New York Supreme Court: Scott v. Dominion Energy, Inc., et al. (Index No. 654722/2026) and Clark v. Dominion Energy, Inc., et al. (Index No. 654742/2026).
- · The lawsuits allege negligent misrepresentation, concealment, and negligence under New York law.
- · Dominion Energy received multiple demand letters from purported shareholders.
- · Supplemental disclosures include details of a March 26, 2026 call between Mr. Blue and Party A's CEO regarding a higher premium, and a non-disclosure and standstill agreement with Party A executed on March 27, 2026.
- · Lazard's sum-of-the-parts DCF analysis for NextEra Energy and Dominion Energy includes segment-level net debt calculations.
- · Comparable company analysis multiples for utility and IPP peers are provided for 2026E and 2027E.
Get daily alerts with 10 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Pre-Market SEC Filings Roundup
🇺🇸 More from United States
View all →August 17, 2026
USA Corporate Events Calendar — August 17, 2026
USA Corporate Events Calendar
August 17, 2026
S&P 500 Technology Sector SEC Filings — August 17, 2026
S&P 500 Technology Sector SEC Filings
August 17, 2026
Nasdaq 100 Stocks SEC Filings — August 17, 2026
Nasdaq 100 Stocks SEC Filings
August 17, 2026
S&P 500 Financials Sector SEC Filings — August 17, 2026
S&P 500 Financials Sector SEC Filings